Skip to Content
Merck
CN

MAB8535

Anti-Herpes Virus 6 Antibody, 101kDa protein, clone C3108-103

clone C3108-103, Chemicon®, from mouse

Synonym(s):

HHV-6B

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Anti-Herpes Virus 6 Antibody, 101kDa protein, clone C3108-103, clone C3108-103, Chemicon®, from mouse

biological source

mouse

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

C3108-103, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable

isotype

IgG

shipped in

wet ice

Quality Level

300

Application

Indirect immunofluorescence at 1:50+ (infected culture cells).

Immunohistochemistry, IH/IH(P)

Dilute with buffer pH 7.5-8.0 to desired working volume.

For extensive dilution, protein containing or other stabilizing medium should be used.

Final working dilutions must be determined by end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
This Anti-Herpes Virus 6 Antibody, 101kDa protein, clone C3108-103 is validated for use in IF, WB, IH for the detection of Herpes Virus 6.

Biochem/physiol Actions

Human herpesvirus 6, B variant. Recognizes a viron protein of 101 kDa.

SPECIES REACTIVITIES:

Shows weak reactivity to cells infected with human CMV in immunofluorescent assays. Does not cross-react with HHV-6 A variant.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Immunogen

Epitope: 101kDa protein

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Physical form

Format: Purified
In 0.02M phoshate buffer, containing 0.25M NaCl and 0.1% Sodium Azide, pH 7.6.

Preparation Note

Maintain at 2-8°C for up to 12 months.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Quantitative HHV-6B antigenemia test for the monitoring of transplant patients.
R Loginov,T Karlsson,K Hockerstedt,D Ablashi,I Lautenschlager
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology null
Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses.
Liisa Volin, Irmeli Lautenschlager, Eeva Juvonen, Anne Nihtinen, Veli-Jukka Anttila, Tapani Ruutu
British Journal of Haematology null
HHV-6 and HHV-7 antigenemia related to CMV infection after liver transplantation.
Maiju Harma, Krister Hockerstedt, Outi Lyytikainen, Irmeli Lautenschlager
Journal of Medical Virology null
Human herpesvirus 6 and cytomegalovirus in ileocolonic mucosa in inflammatory bowel disease.
Taina Sipponen,Ulla Turunen,Irmeli Lautenschlager,Urpo Nieminen,Johanna Arola,Leena Halme
Scandinavian Journal of Gastroenterology null
D J Mock et al.
Journal of neurovirology, 5(4), 363-373 (1999-08-27)
Progressive Multifocal Leukoencephalopathy (PML) is a primary demyelinating disease of the central nervous system occurring almost exclusively in individuals with impaired cell-mediated immunity. The JC polyoma virus has been accepted as the etiologic agent ofPML. Using a two-step in-situ polymerase
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service